- Trials with a EudraCT protocol (181)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
181 result(s) found for: Intraperitoneal.
Displaying page 1 of 10.
| EudraCT Number: 2022-002134-14 | Sponsor Protocol Number: 1.0 | Start Date*: 2022-09-02 |
| Sponsor Name:Catharina Hospital Eindhoven | ||
| Full Title: Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases – a phase II study | ||
| Medical condition: Patients with peritoneal carcinomatosis of colorectal origin | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-015236-15 | Sponsor Protocol Number: NILA/01/09 | Start Date*: 2010-01-22 |
| Sponsor Name:Department of Surgery, National University of Ireland | ||
| Full Title: NEBULISED INTRAPERITONEAL LOCAL ANAESTHETIC (NILA) FOR LAPAROSCOPIC SURGERY: A PROSPECTIVE, RANDOMISED, DOUBLE BLINDED, PLACEBO CONTROLLED CLINICAL TRIAL | ||
| Medical condition: Post operative shoulder tip pain following laparoscopic appendectomy, cholecystectomy, laparoscopic Nissen fundoplication or diagnostic laparoscopy. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: IE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-000701-77 | Sponsor Protocol Number: AGO/2012/002 | Start Date*: 2012-05-03 | |||||||||||
| Sponsor Name:Ghent University Hospital | |||||||||||||
| Full Title: Cytoreduction followed by Normothermic versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion: a Phase II Study in Peritoneal Carcinomatosis | |||||||||||||
| Medical condition: Patients with peritoneal carcinomatosis from colorectal origin (including appendiceal mucinous neoplasms and the pseudomyxoma syndromes) amenable for cytoreduction and Hyperthermic Intraperitoneal ... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2006-003737-33 | Sponsor Protocol Number: 2006-07 | Start Date*: 2006-10-05 |
| Sponsor Name:Örebro University Hospital | ||
| Full Title: Continuous Intraperitoneal Infusion of Local Anesthetics vs. Patient Controlled Intraperitoneal injection for Postoperative Pain relief following Abdominal Hysterectomy. A randomized, double-blind ... | ||
| Medical condition: Postoperative pain after open abdominal hysterectomy | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-001700-39 | Sponsor Protocol Number: IP-REM-PK-01-EU | Start Date*: 2005-09-14 | |||||||||||
| Sponsor Name:Fresenius Biotech GmbH | |||||||||||||
| Full Title: Determination of systemic exposure and characterization of pharmacokinetics of the tri-functional antibody catumaxomab (anti-EpCAM X anti-CD3) administered intraperitoneally in EpCAM positive cance... | |||||||||||||
| Medical condition: epithelial cell adhesion molecule (EpCAM) expressing tumors in patients with malignant ascites requiring therapeutic ascites puncture | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-000882-34 | Sponsor Protocol Number: AGO/2014/002 | Start Date*: 2014-06-03 | |||||||||||
| Sponsor Name:University Hospital Ghent | |||||||||||||
| Full Title: Catheter based adjuvant intraperitoneal chemotherapy for carcinomatosis. | |||||||||||||
| Medical condition: carcinomatosis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2013-000138-37 | Sponsor Protocol Number: PERISCOPE | Start Date*: 2013-09-25 | ||||||||||||||||
| Sponsor Name:NKI-AvL | ||||||||||||||||||
| Full Title: Treatment of PERItoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy | ||||||||||||||||||
| Medical condition: Gastric cancer with peritoneal carcinomatosis or positive peritoneal cytology. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2019-003357-29 | Sponsor Protocol Number: PROICM2019-08INT | Start Date*: 2019-12-03 |
| Sponsor Name:Institut Régional du Cancer de Montpellier (ICM) | ||
| Full Title: Intensive intraperitoneal therapy in advanced ovarian cancer combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) and postoperative intraperitoneal chemotherapy (I... | ||
| Medical condition: Patient with high-grade serous (high grade according to MD Anderson, grade II and III according to Silverman) ovarian or tubal or primitive peritoneal histologically proven cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-004103-12 | Sponsor Protocol Number: ISOTOVE | Start Date*: Information not available in EudraCT |
| Sponsor Name:Centre Jean Perrin | ||
| Full Title: ISOTOVE study Isotopic study of the intraperitoneal distribution of locoregional post surgery chemotherapy for peritoneal carcinomatosis of ovarian origin | ||
| Medical condition: peritoneal carcinomatosis of ovarian origin | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-002850-38 | Sponsor Protocol Number: PI-0327-2013 | Start Date*: 2015-05-21 |
| Sponsor Name:FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DE CÓRDOBA | ||
| Full Title: EFFICACY AND SAFETY OF EARLY POSTOPERATIVE CHEMOTHERAPY INTRAPERITONEAL (EPIC) WITH PACLITAXEL IN THE RADICAL SURGERY TREATMENT OF OVARIAN PERITONEAL CARCINOMATOSIS | ||
| Medical condition: ovarian peritoneal carcinomatosis | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-002738-55 | Sponsor Protocol Number: 69HCL16-0134 | Start Date*: 2017-01-06 | |||||||||||
| Sponsor Name:Hospices Civils de Lyon | |||||||||||||
| Full Title: Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal Carcinosis ( IPOXA ) | |||||||||||||
| Medical condition: Patients with peritoneal carcinosis of colorectal origin and uncertain resectability with an indication for systemic chemotherapy compatible with the FOLFIRI + bevacizumab combination. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-004679-37 | Sponsor Protocol Number: GECOP-MMC | Start Date*: Information not available in EudraCT |
| Sponsor Name:Hospital Universitario de Fuenlabrada | ||
| Full Title: Phase IV multicentric clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with Mytomicin-C after complete surgical cytoreduction in patients with Colon Canc... | ||
| Medical condition: Surgical resection combined with intraperitoneal chemotherapy (CT) is the best treatment for selected patients with Peritoneal Metastases from colon cancer. However, the real role of intraperitonea... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-001005-82 | Sponsor Protocol Number: TALL/IP/2 | Start Date*: 2015-05-05 |
| Sponsor Name:Galileo Research Srl | ||
| Full Title: Phase II trial of intraperitoneal MHC unrestricted adoptive cell therapy with TALL-104 cells in patients with ovarian carcinoma with minimal or microscopic residual disease at second look laparotom... | ||
| Medical condition: Ovarian carcinoma (FIGO stage IIIA and IIIB/IIIC/IV; patients with extra-abdominal disease will be excluded by the study unless those with pleural effusion) with minimal/microscopic residual disease. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: IT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-002309-39 | Sponsor Protocol Number: 60/2011 | Start Date*: 2016-07-08 |
| Sponsor Name:Osakidetza | ||
| Full Title: EFFECTIVENESS OF ROPIVACAINE 0.1% INTRAPERITONEAL IN POSTOPERATIVE PAIN CONTROL IN GYNECOLOGIC LAPAROSCOPIC SURGERY " | ||
| Medical condition: EFECTIVENESS OF ROPIVACAINE 0,1% FOR PAIN CONTROL AFTER LAPAROSCOPIC GYNECOLOGICAL SURGERY | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-004280-31 | Sponsor Protocol Number: 04/280507 | Start Date*: 2006-02-02 |
| Sponsor Name:University of Dundee | ||
| Full Title: Hyperthermic Intraperitoneal Chemotherapy - Gastric Cancer | ||
| Medical condition: Gastric Cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-002687-26 | Sponsor Protocol Number: DGC OC 2006/3 | Start Date*: 2006-11-02 |
| Sponsor Name:Rigshospital, Finsencenter, Afsnit 3994 | ||
| Full Title: En fase I / II forsøg med intraperitoneal Paclitaxel og Carboplatin efter cytoreduktiv operation som behandling af Patienter med ovarie carcinoma med peritoneal carcinose eller primær peritoneal ca... | ||
| Medical condition: Patienter med histologisk påvist primær peritoneal karcinom eller ovarie carcinoma med peritoneal carcinose efter makroskopisk radikal operation (residual disease mindre end 1 cm) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: DK (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-004398-22 | Sponsor Protocol Number: 1 | Start Date*: 2013-07-01 |
| Sponsor Name:Afd. A, OUH | ||
| Full Title: intraperitoneal microdialysis after server peritonitis | ||
| Medical condition: server peritonitis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-011207-23 | Sponsor Protocol Number: | Start Date*: 2009-08-05 |
| Sponsor Name:Hull and east Yorkshire Hospital NHS Trust [...] | ||
| Full Title: A study to Investigate the Effect of Intraperitoneal Levobupivacaine on Post Operative Laparoscopic Pain | ||
| Medical condition: Post operative pain | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-000384-87 | Sponsor Protocol Number: AGO/2013/001 | Start Date*: 2013-03-05 | |||||||||||
| Sponsor Name:Ghent University Hospital | |||||||||||||
| Full Title: Intraperitoneal atomization of levobupivacaine during gynecological laparoscopic procedures : Impact on pain, opioid use and length of recovery room stay (IPLA). | |||||||||||||
| Medical condition: Patients who are planned for gynecological laparoscopic interventions on an ambulatory basis. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2017-001688-20 | Sponsor Protocol Number: AGO/2017/003 | Start Date*: 2017-08-25 |
| Sponsor Name:Ghent University Hospital | ||
| Full Title: INTRAPERITONEAL AEROSOLISATION OF ALBUMIN-STABILIZED PACLITAXEL NANOPARTICLES FOR PERITONEAL CARCINOMATOSIS – PHASE I/II STUDY PROTOCOL | ||
| Medical condition: peritoneal carcinomatosis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) DK (Completed) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
